Michele Jehenson, DDS
Pain Medicine · Stanford
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 10
- 2 carriers
- Office
- 1
On the public record
- 1 Medical Board action on record
Offices
1 location
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Jehenson’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence G37677 · Current
Licensed to practise in California · since 1978 · expires 2028-03-31 · University of Southern California Keck School of Medicine. Board flags: Probation Completed.
Matched on the licence number without its letter prefix; check the name before relying on it.
Public record actions
| 2008-12-22 | Board disciplineDiscipline | Probation completed. · 06 2001119575 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$18,069
Medicare paid this office $18,069 for 89 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (60+ min) | 56 | $10,237 | $183 |
| Return visit (30+ min) | 39 | $5,769 | $103 |
Who their Medicare patients are
89 Original Medicare patients in 2024. Average age 71 · Women 79% · Also on Medicaid 23% · Health risk score 1.06. At or below the middle of the specialty; the typical oral surgery (dentist only) clinician is at 1.13.
Conditions among them: High blood pressure 47% · Depression 35% · Diabetes 18% · Coronary heart disease 16% · Chronic kidney disease 12% · Cancer 12%.
The office billed $82,497, Medicare allowed $23,531 and paid $18,069; for 136 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 89 | 136 | 71 | 1.06 | $82,497 | $18,069 |
| 2023 | 89 | 123 | 70 | 1.27 | $63,162 | $13,902 |
| 2022 | 66 | 93 | 67 | 0.99 | $40,890 | $10,797 |
| 2021 | 92 | 127 | 70 | 1.03 | $76,369 | $15,130 |
| 2020 | 43 | 61 | 67 | 1.13 | $34,495 | $6,442 |
| 2019 | 49 | 69 | 69 | 1.21 | $10,754 | $7,194 |
| 2018 | 76 | 104 | 69 | 1.34 | $15,460 | $10,014 |
| 2017 | 103 | 158 | 69 | 1.12 | $38,865 | $14,896 |
| 2016 | 61 | 97 | 68 | 1.01 | $27,685 | $8,708 |
| 2015 | 64 | 96 | 68 | 0.90 | $35,091 | $11,667 |
| 2014 | 62 | 84 | 70 | 0.99 | $26,086 | $9,174 |
| 2013 | 39 | 63 | 72 | 1.15 | $14,832 | $6,149 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| New patient visit (60+ min) | 48 | $7,595 | $158 |
| Return visit (30+ min) | 28 | $2,665 | $83 |
| Short return visit (20+ min) | 12 | $720 | $55 |
2022: 2 services
| New patient visit (60+ min) | 39 | $6,361 | $163 |
| Return visit (30+ min) | 20 | $1,933 | $84 |
2021: 3 services
| New patient visit (60+ min) | 66 | $10,116 | $153 |
| Long return visit (40+ min) | 13 | $2,172 | $128 |
| Return visit (30+ min) | 14 | $1,165 | $78 |
2020: 1 service
| New patient visit (60+ min) | 29 | $4,372 | $151 |
2019: 3 services
| New patient visit (60+ min) | 32 | $4,823 | $151 |
| Return visit (30+ min) | 14 | $1,136 | $71 |
| Short return visit (20+ min) | 13 | $612 | $44 |
2018: 3 services
| New patient visit (60+ min) | 37 | $5,160 | $139 |
| New patient visit (45+ min) | 19 | $2,493 | $131 |
| Short return visit (20+ min) | 17 | $1,140 | $46 |
2017: 4 services
| New patient visit (60+ min) | 47 | $6,600 | $140 |
| New patient visit (45+ min) | 25 | $3,018 | $121 |
| Short return visit (20+ min) | 27 | $2,526 | $55 |
| Return visit (30+ min) | 17 | $1,703 | $81 |
2016: 4 services
| New patient visit (60+ min) | 25 | $3,486 | $139 |
| New patient visit (45+ min) | 15 | $1,593 | $106 |
| Short return visit (20+ min) | 14 | $1,331 | $55 |
| Return visit (30+ min) | 11 | $1,073 | $72 |
2015: 3 services
| New patient visit (60+ min) | 25 | $3,752 | $150 |
| New patient visit (45+ min) | 14 | $1,986 | $142 |
| Return visit (30+ min) | 12 | $1,194 | $85 |
2014: 3 services
| New patient visit (60+ min) | 15 | $2,246 | $150 |
| New patient visit (45+ min) | 15 | $2,194 | $146 |
| Return visit (30+ min) | 11 | $1,369 | $98 |
2013: 1 service
| New patient visit (45+ min) | 17 | $2,578 | $152 |
Drugs they prescribed that Part D paid
$1,396
Pharmacies billed $1,396 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 51) in 2024. At or below the middle of the specialty; the typical oral surgery (dentist only) clinician is at 22%.
49 generic and fewer than 11 brand-name prescriptions · $1,396 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Pregabalin | 13 | $180 | $14 |
Year by year
| 2024 | 51 | 23 | 0% (0) | None | $1,396 |
| 2023 | 41 | 20 | 0% (0) | 0% | $930 |
| 2022 | 53 | 19 | 0% (0) | 0% | $1,463 |
| 2021 | 39 | 19 | 0% (0) | 0% | $1,197 |
| 2020 | 17 | None | 0% (0) | None | $7,706 |
| 2019 | 51 | 18 | None | None | $5,252 |
| 2018 | 52 | 21 | 0% (0) | None | $2,920 |
| 2017 | 48 | 14 | None | None | $2,976 |
| 2016 | 59 | 18 | None | None | $10,449 |
| 2015 | 43 | 17 | 0% (0) | None | $3,493 |
| 2014 | 36 | 13 | None | None | $2,627 |
| 2013 | 70 | 16 | None | None | $3,432 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Gabapentin | 11 | $175 | $16 |
2021: 1 drug
| Pregabalin | 14 | $544 | $39 |
2018: 2 drugs
| Gabapentin | 13 | $179 | $14 |
| Duloxetine | 12 | $106 | $9 |
2017: 1 drug
| Gabapentin | 11 | $225 | $20 |
2016: 1 drug
| Lidocaine | 26 | $5,857 | $225 |
2015: 1 drug
| Clonazepam | 11 | $30 | $3 |
2013: 2 drugs
| Gabapentin | 22 | $877 | $40 |
| Clonazepam | 31 | $574 | $19 |
Money from drug and device companies
$129 in 2025
| 2025 | 1 | 4 | None | $129 |
| 2024 | 1 | 1 | None | $130 |
| 2023 | 1 | 1 | None | $110 |
| 2019 | 2 | 2 | None | $174 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Colgate Oral Pharmaceuticals | None | $129 | 4 payments
|
See all 4 published payments
| Colgate Oral Pharmaceuticals | Education · 2025-01-24 | None | $24 |
| Colgate Oral Pharmaceuticals | Education · 2025-01-23 | None | $39 |
| Colgate Oral Pharmaceuticals | Education · 2025-01-22 | None | $31 |
| Colgate Oral Pharmaceuticals | Education · 2025-01-20 | None | $35 |
See earlier years (2024, 2023, 2019)
2024: $130
| Lundbeck | Vyepti | $130 | 1 payment
|
2023: $110
| Impel Pharmaceuticals | Trudhesa | $110 | 1 payment
|
2019: $174
| Teva Pharmaceuticals USA | Ajovy | $116 | 1 payment
|
| Collegium Pharmaceutical | Xtampza Er | $58 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1649445826
- Licence
- CA 37677California G37677: Current · expires 2028-03-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207LP2900X (207LP2900X); Federal specialty code 122300000X (122300000X); Federal specialty code 1223X2210X (1223X2210X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2008-04-28
- NPI last updated
- 2024-04-11
- NPI record certified
- 2024-04-11
This is when the NPI record was last certified, not a medical board exam.